|
1
|
Fitzmorris P, Shoreibah M, Anand BS and
Singal AK: Management of hepatocellular carcinoma. J Cancer Res
Clin Oncol. 141:861–876. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fernández-Rodríguez CM and
Gutiérrez-García ML: Prevention of hepatocellular carcinoma in
patients with chronic hepatitis B. World J Gastrointest Pharmacol
Ther. 5:175–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hartke J, Johnson M and Ghabril M: The
diagnosis and treatment of hepatocellular carcinoma. Semin Diagn
Pathol. 34:153–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Banaudha KK and Verma M: Epigenetic
biomarkers in liver cancer. Methods Mol Biol. 1238:65–76. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thakral S and Ghoshal K: miR-122 is a
unique molecule with great potential in diagnosis, prognosis of
liver disease, and therapy both as miRNA mimic and antimir. Curr
Gene Ther. 15:142–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cicciù M, Herford AS, Cervino G, Troiano
G, Lauritano F and Laino L: Tissue fluorescence imaging (VELscope)
for quick non-invasive diagnosis in oral pathology. J Craniofac
Surg. 28:e112–e115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Luo Q, Li Y, Deng S, Wei S and Li
X: Radiofrequency ablation versus hepatic resection for small
hepatocellular carcinomas: A meta-analysis of randomized and
nonrandomized controlled trials. PLoS One. 9:e844842014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW,
Han JK and Choi BI: Small (≤1-cm) hepatocellular carcinoma:
Diagnostic performance and imaging features at gadoxetic
acid-enhanced MR imaging. Radiology. 271:748–760. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong YM, Yoon KT, Cho M, Heo J, Woo HY and
Lim W: A case of small hepatocellular carcinoma with an extensive
lymph node metastasis at diagnosis. Clin Mol Hepatol. 20:310–312.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang YY, Wang XY, Guo XM and Jiang XX:
Small hepatocellular carcinoma in patients with hepatitis B-induced
cirrhosis: a comparison between MRI and MDCT. Beijing Da Xue Xue
Bao. 42:767–772. 2010.(Article in Chinese). PubMed/NCBI
|
|
12
|
Kim JM, Kwon CH, Joh JW, Park JB, Lee JH,
Kim SJ, Paik SW, Park CK and Yoo BC: Differences between
hepatocellular carcinoma and hepatitis B virus infection in
patients with and without cirrhosis. Ann Surg Oncol. 21:458–465.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lv P, Lin XZ, Li J, Li W and Chen K:
Differentiation of small hepatic hemangioma from small
hepatocellular carcinoma: Recently introduced spectral CT method.
Radiology. 259:720–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi BI, Takayasu K and Han MC: Small
hepatocellular carcinomas and associated nodular lesions of the
liver: Pathology, pathogenesis, and imaging findings. AJR Am J
Roentgenol. 160:1177–1187. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Gao Y, Shi W, Zhai D, Rao Q, Jia
X, Liu J, Jiao X and Du Z: Profiles of differential expression of
circulating microRNAs in hepatitis B virus-positive small
hepatocellular carcinoma. Cancer Biomark. 15:171–180. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hagel M, Miduturu C, Sheets M, Rubin N,
Weng W, Stransky N, Bifulco N, Kim JL, Hodous B, Brooijmans N, et
al: First selective small molecule inhibitor of FGFR4 for the
treatment of hepatocellular carcinomas with an activated FGFR4
signaling pathway. Cancer Discov. 5:424–437. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang R, Luo Y, Yang S, Lin J, Gao D, Zhao
Y, Liu J, Shi X and Wang X: Hyaluronic acid-modified
manganese-chelated dendrimer-entrapped gold nanoparticles for the
targeted CT/MR dual-mode imaging of hepatocellular carcinoma. Sci
Rep. 6:338442016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sattler B, Lee JA, Lonsdale M and Coche E:
PET/CT (and CT) instrumentation, image reconstruction and data
transfer for radiotherapy planning. Radiother Oncol. 96:288–297.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chou CT, Chen RC, Lin WC, Ko CJ, Chen CB
and Chen YL: Prediction of microvascular invasion of hepatocellular
carcinoma: Preoperative CT and histopathologic correlation. AJR Am
J Roentgenol. 203:W253–W259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu JJ, Li HX, Chen ZB, Yang WP, Zhao SF,
Chen J, Bai T, Li H and Li LQ: Consistency analysis of
contrast-enhanced ultrasound and contrast-enhanced CT in diagnosis
of small hepatocellular carcinoma. Int J Clin Exp Med.
8:21466–21471. 2015.PubMed/NCBI
|
|
21
|
Sahinarslan A, Erbas G, Kocaman SA, Bas D,
Akyel A, Karaer D, Ergun MA, Arac M and Boyaci B: Comparison of
radiation-induced damage between CT angiography and conventional
coronary angiography. Acta Cardiol. 68:291–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schiebler ML, Bhalla S, Runo J, Jarjour N,
Roldan A, Chesler N and François CJ: Magnetic resonance and
computed tomography imaging of the structural and functional
changes of pulmonary arterial hypertension. J Thorac Imaging.
28:178–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao XT, Li WX, Chai WM and Chen KM:
Detection of small hepatocellular carcinoma using gadoxetic
acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.
0T beneficial? J Dig Dis. 15:137–145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hwang J, Kim SH, Lee MW and Lee JY: Small
(≤2 cm) hepatocellular carcinoma in patients with chronic liver
disease: Comparison of gadoxetic acid-enhanced 3.0 T MRI and
multiphasic 64-multirow detector CT. Br J Radiol. 85:e314–e322.
2012. View Article : Google Scholar : PubMed/NCBI
|
